Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3626
CALL
Brighthouse Financial
BHF
$3.37B
| $5.19M | ﹤0.01% |
126,500
+30,800
| +32% | +$1.49M |
|
3627
Insmed
INSM
$27B
| $5.18M | ﹤0.01% |
262,800
+108,512
| +70% | +$2.27M |
|
3628
Standard Motor Products
SMP
$870M
| $5.18M | ﹤0.01% |
115,172
+77,847
| +209% | +$3.23M |
|
|
NEWR
3629
PUT
DELISTED
New Relic, Inc.
NEWR
| $5.18M | ﹤0.01% |
103,500
-88,100
| -46% | -$4.89M |
|
3630
Forward Air
FWRD
$640M
| $5.18M | ﹤0.01% |
56,301
+24,783
| +79% | +$2.3M |
|
3631
PUT
FLEX LNG
FLNG
$1.67B
| $5.17M | ﹤0.01% |
188,900
+83,300
| +79% | +$2.33M |
|
3632
Evolus
EOLS
$539M
| $5.17M | ﹤0.01% |
445,903
+194,302
| +77% | +$2.29M |
|
3633
Northwest Bancshares
NWBI
$2.31B
| $5.17M | ﹤0.01% |
403,990
+11,851
| +3% | +$151K |
|
|
EAC
3634
DELISTED
Edify Acquisition Corp. Class A Common Stock
EAC
| $5.17M | ﹤0.01% |
526,456
-538,557
| -51% | -$5.28M |
|
|
ANSS
3635
PUT
DELISTED
Ansys
ANSS
| $5.17M | ﹤0.01% |
21,600
+1,800
| +9% | +$476K |
|
3636
Invesco Mortgage Capital
IVR
$805M
| $5.17M | ﹤0.01% |
352,094
+37,730
| +12% | +$637K |
|
3637
CALL
Freshworks
FRSH
$3.5B
| $5.16M | ﹤0.01% |
392,700
+80,700
| +26% | +$1.26M |
|
3638
PUT
Aurinia Pharmaceuticals
AUPH
$2.06B
| $5.16M | ﹤0.01% |
513,500
-810,600
| -61% | -$9.06M |
|
3639
iShares World ex U.S. Carbon Transition Readiness Aware Active ETF
LCTD
$295M
| $5.16M | ﹤0.01% |
135,993
+32,805
| +32% | +$1.36M |
|
3640
PUT
Sonos
SONO
$1.93B
| $5.15M | ﹤0.01% |
285,700
-109,500
| -28% | -$2.46M |
|
|
MRTX
3641
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $5.15M | ﹤0.01% |
76,720
+57,909
| +308% | +$3.68M |
|
3642
PUT
Lightspeed Commerce
LSPD
$1.38B
| $5.15M | ﹤0.01% |
230,800
+40,600
| +21% | +$956K |
|
3643
AngioDynamics
ANGO
$655M
| $5.14M | ﹤0.01% |
265,882
+46,937
| +21% | +$961K |
|
3644
PUT
LGI Homes
LGIH
$1.39B
| $5.14M | ﹤0.01% |
59,200
+35,400
| +149% | +$3.28M |
|
3645
John Wiley & Sons Class A
WLY
$2.61B
| $5.14M | ﹤0.01% |
107,562
+92,664
| +622% | +$4.74M |
|
3646
PUT
Xcel Energy
XEL
$49.5B
| $5.14M | ﹤0.01% |
72,600
+62,500
| +619% | +$4.55M |
|
|
JNCE
3647
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $5.14M | ﹤0.01% |
1,694,867
-6,687
| -0.4% | -$32.5K |
|
3648
CALL
Murphy Oil
MUR
$4.96B
| $5.13M | ﹤0.01% |
170,000
-52,300
| -24% | -$2.02M |
|
3649
PUT
Carlyle Group
CG
$17.6B
| $5.13M | ﹤0.01% |
162,000
+44,100
| +37% | +$1.69M |
|
|
FAZ
3650
PUT
Direxion Daily Financial Bear 3x ETF
FAZ
$84.6M
| $5.13M | ﹤0.01% |
17,722
+4,689
| +36% | +$1.14M |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.